Home / TLPH : NASDAQ

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does TLPH make money? Does TLPH have pricing power? What's the Earnings Whisper? Will TLPH profit more as the business scales? What is TLPH's management track record? Is TLPH's current price justified?

Talphera, Inc.

$1.24 +$0.08 (+6.90%)

NASDAQ · 14 Sep 2026 20:00 UTC

Previous Close

$1.24

Day Range

$1.21$1.25

Year Range

$0.69$1.57

Market Cap

64.36M

AVG Volume

267.61K

Trailing/Forward PE

-3.88/-

PEG ratio

-0.78

Dividend Yield

Next Earnings Date

2026-11-11

Primary Exchange

NASDAQ

Revenue (USD)

TLPH Revenue (USD) by quarter
Period	Revenue (USD)
26 Q2	0
26 Q1	0
25 Q4	0
25 Q3	1K
25 Q2	0
25 Q1	27K
24 Q4	0
24 Q3	0
24 Q2	0
24 Q1	0

Net Income (USD)

TLPH Net Income (USD) by quarter
Period	Net Income (USD)
26 Q2	-4.31M
26 Q1	-2.56M
25 Q4	-3.77M
25 Q3	-4.44M
25 Q2	-3.49M
25 Q1	-2.59M
24 Q4	-1.87M
24 Q3	-3.35M
24 Q2	-3.83M
24 Q1	-3.95M

Operating Income (USD)

TLPH Operating Income (USD) by quarter
Period	Operating Income (USD)
26 Q2	-3.92M
26 Q1	-3.95M
25 Q4	-3.45M
25 Q3	-3.42M
25 Q2	-3.69M
25 Q1	-2.92M
24 Q4	-3M
24 Q3	-3.75M
24 Q2	-4.27M
24 Q1	-4.24M

EBITDA (USD)

TLPH EBITDA (USD) by quarter
Period	EBITDA (USD)
26 Q2	-3.36M
26 Q1	-2.56M
25 Q4	-3.77M
25 Q3	-4.44M
25 Q2	-3.49M
25 Q1	250K
24 Q4	-1.85M
24 Q3	-3.33M
24 Q2	-3.59M
24 Q1	-3.75M

Cash Flows (USD)

TLPH Cash Flows (USD) by quarter
Period	Cash Flows (USD)
26 Q2	-3.92M
26 Q1	-3.4M
25 Q4	-2.44M
25 Q3	-2.51M
25 Q2	-2.95M
25 Q1	-3.47M
24 Q4	-2.25M
24 Q3	-2.94M
24 Q2	-4.61M
24 Q1	-2.88M

EPS (USD)

TLPH EPS (USD) by quarter
Period	EPS (USD)
26 Q2	-0.06
26 Q1	-0.06
25 Q4	-0.09
25 Q3	-0.11
25 Q2	-0.1
25 Q1	-0.1
24 Q4	-0.07
24 Q3	-0.13
24 Q2	-0.15
24 Q1	-0.16

Expenses (USD)

TLPH Expenses (USD) by quarter
Period	Expenses (USD)
26 Q2	3.92M
26 Q1	3.95M
25 Q4	3.45M
25 Q3	3.42M
25 Q2	3.69M
25 Q1	1.17M
24 Q4	1.32M
24 Q3	2.05M
24 Q2	1.91M
24 Q1	1.43M

Cash & Debt (USD)

TLPH Cash & Debt (USD) by quarter
Period	Cash & Debt (USD)
26 Q2	17.08M
26 Q1	21.11M
25 Q4	20.38M
25 Q3	21.29M
25 Q2	6.79M
25 Q1	5.39M
24 Q4	8.86M
24 Q3	11.12M
24 Q2	14.02M
24 Q1	18.58M

Debt ratios

TLPH Debt ratios by quarter
Period	Debt ratios
26 Q2	1.21
26 Q1	1.48
25 Q4	1.21
25 Q3	1.55
25 Q2	0.03
25 Q1	-0.13
24 Q4	0.19
24 Q3	0.3
24 Q2	0.57
24 Q1	0.87

Margins

TLPH Margins by quarter
Period	Margins
25 Q3	100%
25 Q1	-4229.63%
23 Q4	-529.54%
23 Q3	-906.84%
23 Q2	-513.44%
22 Q4	-43.65%
22 Q2	-53.68%
21 Q4	-61600%
21 Q3	63.45%
21 Q2	-134.76%

Return on Capital

TLPH Return on Capital by quarter
Period	Return on Capital
26 Q2	-29.93%
26 Q1	-13.83%
25 Q4	-22.14%
25 Q3	-23.13%
25 Q2	-52.65%
25 Q1	-46.31%
24 Q4	-23.37%
24 Q3	-34.78%
24 Q2	-30.06%
24 Q1	-24.21%

Shares Outstanding

TLPH Shares Outstanding by quarter
Period	Shares Outstanding
26 Q2	75.53M
26 Q1	42.41M
25 Q4	42.41M
25 Q3	41.45M
25 Q2	34.53M
25 Q1	26.27M
24 Q4	26.24M
24 Q3	26.21M
24 Q2	26.2M
24 Q1	24.72M

Book Value Per Share (USD)

TLPH Book Value Per Share (USD) by quarter
Period	Book Value Per Share (USD)
26 Q2	0.19
26 Q1	0.44
25 Q4	0.4
25 Q3	0.46
25 Q2	0.19
25 Q1	0.21
24 Q4	0.3
24 Q3	0.37
24 Q2	0.49
24 Q1	0.66

Total Assets (USD)

TLPH Total Assets (USD) by quarter
Period	Total Assets (USD)
26 Q2	26.81M
26 Q1	30.16M
25 Q4	29.72M
25 Q3	30.74M
25 Q2	16.52M
25 Q1	14.99M
24 Q4	18.24M
24 Q3	21.01M
24 Q2	24.86M
24 Q1	28.77M

Employee Count

TLPH Employee Count by quarter
Period	Employee Count
2025	12
2024	13

PE Ratio

TLPH PE Ratio by quarter
Period	PE Ratio
Aug 23	0.25
Aug 23	0.2
Aug 23	0.2
Aug 23	0.22
Jul 23	0.22
Jul 23	0.23
Jul 23	0.27
Jul 23	0.29
Jun 23	0.25
Jun 23	0.25
Jun 23	0.27
Jun 23	0.28
Jun 23	0.23
May 23	0.17
May 23	0.12
May 23	0.12
May 23	0.1
Apr 23	0.1
Apr 23	0.11
Apr 23	0.11
Apr 23	0.1
Mar 23	0.1
Mar 23	0.11
Mar 23	0.1
Mar 23	0.18
Mar 23	0.2
Feb 23	0.22
Feb 23	0.24
Feb 23	0.27
Feb 23	0.32
Jan 23	0.31
Jan 23	0.35
Jan 23	0.4
Jan 23	0.34
Dec 22	0.35
Dec 22	0.32
Dec 22	0.37
Dec 22	0.33
Dec 22	0.35
Nov 22	0.38
Nov 22	0.39
Nov 22	0.33
Nov 22	0.31
Oct 22	0.45
Oct 22	0.65
Oct 22	0.71
Oct 22	0.65
Sep 22	0.68
Sep 22	0.78
Sep 22	0.9
Sep 22	0.9
Sep 22	0.97

Free Cash Flow Yield

TLPH Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Sep 26	-13.1%
Sep 26	-13.1%
Sep 26	-13.54%
Aug 26	-13.54%
Aug 26	-13.65%
Aug 26	-13.21%
Aug 26	-18.62%
Jul 26	-20.8%
Jul 26	-19.73%
Jul 26	-20.02%
Jul 26	-18.24%
Jul 26	-24.89%
Jun 26	-25.85%
Jun 26	-24.43%
Jun 26	-30.49%
Jun 26	-34.36%
May 26	-32.63%
May 26	-32.67%
May 26	-31.4%
May 26	-29.65%
May 26	-29.17%
Apr 26	-34.57%
Apr 26	-33.39%
Apr 26	-35.23%
Apr 26	-37.1%
Mar 26	-36.14%
Mar 26	-32.39%
Mar 26	-33.85%
Mar 26	-31.09%
Feb 26	-29.59%
Feb 26	-34.73%
Feb 26	-33.27%
Feb 26	-33.13%
Jan 26	-28.22%
Jan 26	-26.98%
Jan 26	-26.97%
Jan 26	-25.45%
Jan 26	-23.25%
Dec 25	-24.52%
Dec 25	-24.52%
Dec 25	-22.67%
Dec 25	-21.93%
Nov 25	-20.28%
Nov 25	-20.13%
Nov 25	-21.58%
Nov 25	-27.11%
Oct 25	-25.09%
Oct 25	-29.23%
Oct 25	-31.42%
Oct 25	-27.33%
Oct 25	-35.39%
Sep 25	-37.09%
Sep 25	-39.55%
Sep 25	-35.76%
Sep 25	-61.21%
Aug 25	-62.14%
Aug 25	-68.23%
Aug 25	-79.03%
Aug 25	-123.36%
Aug 25	-125.54%
Jul 25	-119.4%
Jul 25	-123.24%
Jul 25	-97.15%
Jul 25	-112.01%
Jun 25	-107.94%
Jun 25	-110.91%
Jun 25	-103.1%
Jun 25	-99.05%
May 25	-102.89%
May 25	-99.84%
May 25	-100.23%
May 25	-89.53%
May 25	-90.37%
Apr 25	-99.46%
Apr 25	-101.76%
Apr 25	-96.68%
Apr 25	-94.61%
Mar 25	-93.6%
Mar 25	-86.42%
Mar 25	-97.95%
Mar 25	-99.73%
Feb 25	-98.04%
Feb 25	-91.34%
Feb 25	-81.87%
Feb 25	-84.39%
Jan 25	-86.38%
Jan 25	-80.66%
Jan 25	-81.87%
Jan 25	-91.42%
Jan 25	-88.44%
Dec 24	-103.49%
Dec 24	-86.34%
Dec 24	-84.39%
Dec 24	-79.38%
Nov 24	-77.59%
Nov 24	-78.91%
Nov 24	-79.48%
Nov 24	-60.11%
Nov 24	-59.32%
Oct 24	-56.08%

Price to Sales

TLPH Price to Sales by quarter
Period	Price to Sales
Sep 26	93653.36
Sep 26	93653.36
Sep 26	90632.28
Aug 26	90632.28
Aug 26	89877.01
Aug 26	92898.09
Aug 26	60647.32
Jul 26	54285.71
Jul 26	57254.46
Jul 26	56406.25
Jul 26	61919.64
Jul 26	45379.46
Jun 26	43683.03
Jun 26	46227.67
Jun 26	37041.51
Jun 26	32868.3
May 26	34607.14
May 26	34568.97
May 26	35964.28
May 26	1368.81
May 26	1391.37
Apr 26	1173.87
Apr 26	1215.67
Apr 26	1152.06
Apr 26	1094.04
Mar 26	1123.13
Mar 26	1233.09
Mar 26	1179.64
Mar 26	1284.31
Feb 26	1349.6
Feb 26	1149.74
Feb 26	1200.37
Feb 26	1205.41
Jan 26	1415.34
Jan 26	1480.33
Jan 26	1480.48
Jan 26	1569.31
Jan 26	1717.35
Dec 25	1628.53
Dec 25	1628.53
Dec 25	1761.77
Dec 25	1820.99
Nov 25	1969.04
Nov 25	1983.84
Nov 25	1850.6
Nov 25	1585.84
Oct 25	1713.73
Oct 25	1470.74
Oct 25	1368.43
Oct 25	1573.05
Oct 25	1214.96
Sep 25	1159.2
Sep 25	1087.07
Sep 25	1202.17
Sep 25	702.37
Aug 25	691.89
Aug 25	630.12
Aug 25	543.98
Aug 25	398.4
Aug 25	391.49
Jul 25	411.63
Jul 25	398.79
Jul 25	505.91
Jul 25	438.78
Jun 25	455.32
Jun 25	443.15
Jun 25	476.72
Jun 25	496.18
May 25	477.69
May 25	492.29
May 25	490.34
Mar 25	54.66
Mar 25	59.21
Mar 25	52.24
Mar 25	51.31
Feb 25	52.19
Feb 25	56.02
Feb 25	62.5
Feb 25	60.63
Jan 25	59.24
Jan 25	63.43
Jan 25	62.5
Jan 25	55.97
Jan 25	57.85
Dec 24	49.44
Dec 24	59.26
Dec 24	60.63
Dec 24	64.46
Nov 24	65.95
Nov 24	64.84
Nov 24	64.38
Nov 24	59.78
Nov 24	60.57
Oct 24	64.07
Oct 24	72.42
Oct 24	52.01
Oct 24	51.35
Sep 24	56.55
Sep 24	60.53
Sep 24	59.25

EV/EBITDA

TLPH EV/EBITDA by quarter
Period	EV/EBITDA
Aug 23	0.03
Aug 23	-0.01
Aug 23	-0.01
Aug 23	0.01
Jul 23	0.01
Jul 23	0.02
Jul 23	0.05
Jul 23	0.06
Jun 23	0.03
Jun 23	0.03
Jun 23	0.04
Jun 23	0.05
Jun 23	0.02
May 23	0.04
May 23	0
May 23	0
May 23	-0.01
Apr 23	-0.01
Apr 23	-0.01
Apr 23	-0.01
Apr 23	-0.02
Mar 23	-0.01
Mar 23	-0.01
Mar 23	-0.01
Mar 23	0.05
Mar 23	0.07
Feb 23	0.11
Feb 23	0.13
Feb 23	0.16
Feb 23	0.2
Jan 23	0.19
Jan 23	0.22
Jan 23	0.26
Jan 23	0.21
Dec 22	0.22
Dec 22	0.2
Dec 22	0.24
Dec 22	0.2
Dec 22	0.22
Nov 22	0.16
Nov 22	0.16
Nov 22	0.12
Nov 22	0.1
Oct 22	0.21
Oct 22	0.37
Oct 22	0.42
Oct 22	0.37
Sep 22	0.4
Sep 22	0.48
Sep 22	0.58
Sep 22	0.58
Sep 22	0.63

Price to Book

TLPH Price to Book by quarter
Period	Price to Book
Sep 26	6.5
Sep 26	6.5
Sep 26	6.29
Aug 26	6.29
Aug 26	6.24
Aug 26	6.45
Aug 26	3.28
Jul 26	2.94
Jul 26	3.1
Jul 26	3.05
Jul 26	3.35
Jul 26	2.46
Jun 26	2.36
Jun 26	2.5
Jun 26	2
Jun 26	1.78
May 26	1.87
May 26	1.87
May 26	1.95
May 26	2.25
May 26	2.29
Apr 26	1.93
Apr 26	2
Apr 26	1.89
Apr 26	1.8
Mar 26	1.85
Mar 26	1.8
Mar 26	1.72
Mar 26	1.88
Feb 26	1.97
Feb 26	1.68
Feb 26	1.75
Feb 26	1.76
Jan 26	2.07
Jan 26	2.16
Jan 26	2.16
Jan 26	2.29
Jan 26	2.51
Dec 25	2.38
Dec 25	2.38
Dec 25	2.57
Dec 25	2.66
Nov 25	2.87
Nov 25	2.9
Nov 25	2.7
Nov 25	6.46
Oct 25	6.98
Oct 25	5.99
Oct 25	5.58
Oct 25	6.41
Oct 25	4.95
Sep 25	4.72
Sep 25	4.43
Sep 25	4.9
Sep 25	2.86
Aug 25	2.82
Aug 25	2.57
Aug 25	2.22
Aug 25	1.92
Aug 25	1.89
Jul 25	1.99
Jul 25	1.92
Jul 25	2.44
Jul 25	2.12
Jun 25	2.2
Jun 25	2.14
Jun 25	2.3
Jun 25	2.39
May 25	2.3
May 25	2.37
May 25	2.36
May 25	1.77
May 25	1.75
Apr 25	1.59
Apr 25	1.56
Apr 25	1.64
Apr 25	1.68
Mar 25	1.59
Mar 25	1.73
Mar 25	1.52
Mar 25	1.5
Feb 25	1.52
Feb 25	1.63
Feb 25	1.82
Feb 25	1.77
Jan 25	1.73
Jan 25	1.85
Jan 25	1.82
Jan 25	1.63
Jan 25	1.69
Dec 24	1.44
Dec 24	1.73
Dec 24	1.77
Dec 24	1.88
Nov 24	1.92
Nov 24	1.89
Nov 24	1.88
Nov 24	1.87
Nov 24	1.89
Oct 24	2

No video analysis for this stock yet. Request one from our team.

News: TLPH

prnewswire.com · 3 Sep 2026

Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

SAN MATEO, Calif., Sept. 3, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that Company management will be presenting at the H.C.

seekingalpha.com · 13 Aug 2026

Talphera, Inc. (TLPH) Q2 2026 Earnings Call Transcript

prnewswire.com · 12 Aug 2026

Talphera Announces Second Quarter 2026 Financial Results and Provides Corporate Update

NEPHRO CRRT clinical study of nafamostat is 75% enrolled; expected to be complete this year Draft 2026 KDIGO guidelines added nafamostat as an acceptable CRRT anticoagulant, a positive change from previous guidelines Updated market research indicates an estimated 200,000 annual U.S. CRRT procedures, a 21% increase over prior estimates; investor event planned as enrollment nears completion Cash and investments of $17.1 million at June 30, 2026 Conference call and webcast to be held on Wednesday August 12, 2026 at 4:30 pm ET SAN MATEO, Calif., Aug. 12, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced financial results for the second quarter of 2026 and provided a corporate update on the development of nafamostat.

prnewswire.com · 5 Aug 2026

Talphera to Report Second Quarter 2026 Financial Results on Wednesday, August 12, 2026

SAN MATEO, Calif., Aug. 5, 2026 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that it will host a conference call and webcast on Wednesday, August 12, 2026 at 4:30 p.m.